Many people in developing countries have insufficient or no access to health technologies that offer effective, affordable solutions to common diseases and health problems. With the Life Sciences and Health for Development Fund (LS&H4D), the ministry of Foreign Affairs aims to stimulate public-private partnership in the life sciences sector. You can no longer apply for this grant.
Leading expertise on life sciences
The Netherlands has developed unique, leading expertise in the area of Life Sciences and Health. Under the Dutch government’s top sector policy, life sciences enjoy special focus and extra government investment. The Dutch government implements this policy jointly with businesses, research institutions and public sector organisations. In this way, Dutch expertise can be used to develop innovative solutions for public health issues in developing countries.
Improved public health boosts economic development, while improved economic prospects mean better human health. This can open up opportunities for Dutch and local businesses to develop and implement innovative solutions.
Sexual and reproductive health and rights (SRHR)
Moreover, the Netherlands occupies a key international position when it comes to sexual and reproductive health and rights (SRHR). It is seen as a leading international actor in this field. This is due in part to the results it has achieved at home. For example, the Netherlands has one of the lowest rates of teenage pregnancy and abortions worldwide.
Investment in sexual health is a priority, as it results in smaller, healthier and better educated families and a higher demographic dividend. For example when a population’s productivity increases, thus leading to sustained economic growth. That is why the Netherlands is continuing to invest heavily in SRHR as a development policy priority.
The Life Sciences and Health for Development grant is open to Public Private Partnerships. A Public Private Partnership is a contractual partnership without legal personality, consisting of at least one commercial company, one not-for-profit civil society organisation, and one public authority.
The public authority may be a ministry, an independent administrative authority, a provincial or municipal authority. Or, if a non-Dutch public authority, part of the general public administration in the country in question.
Research institutions may also participate in a partnership. At least one party must be based in the Netherlands and one in a developing country.
No party may have a majority interest in any of the other parties or otherwise exercise control over them. Parties representing the government are not eligible for a grant. Accordingly, costs acquired by government parties cannot be included in the project budget.
Including of a civil organisation in the partnership ensures that the target group is involved with the project.
The grant covers no more than 75% of the eligible project costs for each partnership, up to a maximum of:
€ 75,000 for a feasibility research;
€ 225,000 for the development of a ‘proof of principle’ or a ‘proof of concept';
€ 150,000 for a feasibility study;
€ 300,000 for a demonstration project.
During the implementation of your project you have to report to the Netherlands Enterprise Agency. Please use the templates provided under Downloads.
Read the frequently asked questions about partnerships and project administration.
LS&H4D projects, active on or started after January 2015, can be found at the aiddata.rvo.nl portal. This portal offers an overview of all official development aid (ODA) projects and programmes executed by the Netherlands Enterprise Agency (RVO.nl). You can refine your search by using filter options such as country, sector and programme.
See the official documents and relevant publications for Life Sciences and Health for Development.
The World Bank and the World Health Organization (WHO) believe the lack of effective and affordable means of diagnostics, treatment and prevention to be the biggest challenge to controlling poverty-related health problems in developing countries. Poorer groups at the Bottom of the Pyramid (BoP) are disproportionately affected by health problems that are easily preventable and treatable. They would benefit especially from innovative health technologies. These groups constitute the motor of the national economy in many countries and are thus key to their economic growth.
AIDS, tuberculosis, malaria and other poverty-related health problems are still highly prevalent and have a very negative impact on productivity. So do conditions related to sexual and reproductive health. In addition to this, pregnancy and childbirth all too often result in illness and death for new and expectant mothers in developing countries. The temporary or permanent loss of the keystone of the family can have a devastating impact.
The Netherlands Enterprise Agency (RVO.nl) carries out Life Sciences and Health for Development (LS&H4D) for the Dutch Ministry of Foreign Affairs.